Dunvegan Associates’s Sanofi SNY Stock Holding History

Dunvegan Associates’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$5K	Hold	107	–	–	0.01%	190
2015 Q3	$5K	Hold	107	–	–	0.01%	190
2015 Q2	$5K	Hold	107	–	–	0.01%	185
2015 Q1	$5K	Hold	107	–	–	﹤0.01%	196
2014 Q4	$5K	Sell	107 -2,315	-96%	-$112K	﹤0.01%	193
2014 Q3	$137K	Hold	2,422	–	–	0.12%	65
2014 Q2	$129K	Hold	2,422	–	–	0.11%	70
2014 Q1	$127K	Buy	+2,422	New	+$123K	0.11%	68
2013 Q4	–	Sell	-4,630	Closed	-$234K	–	73
2013 Q3	$234K	Hold	4,630	–	–	0.17%	68
2013 Q2	$238K	Buy	+4,630	New	+$247K	0.18%	67

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Dunvegan Associates's SNY Position: Q4 2015 in Review

Dunvegan Associates held its Sanofi (SNY) position steady in Q4 2015 at 107 shares worth $5K. The position accounts for 0.01% of the portfolio, ranked #190.

Dunvegan Associates first reported a position in SNY in Q2 2013 and has held it in 10 quarters since. The position peaked at $238K in Q2 2013. 477 funds tracked by Wall St. Rank hold SNY as of Q4 2015.

Dunvegan Associates held 107 shares of Sanofi worth $5K as of Q4 2015.
Dunvegan Associates left its Sanofi share count unchanged in Q4 2015.
Sanofi made up 0.01% of Dunvegan Associates's portfolio in Q4 2015, its #190 holding.
Dunvegan Associates first reported a position in Sanofi in Q2 2013 and has held it in 10 quarters since.
Dunvegan Associates's Sanofi position peaked at $238K in Q2 2013.
477 funds tracked by Wall St. Rank held Sanofi as of Q4 2015.

Based on Dunvegan Associates's 13F filing for Q4 2015, filed 28 Apr 2017.